New clip fixes leaky heart valve without open surgery

NCT ID NCT04259411

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested the MitraClip device in 51 people in China with a leaky heart valve (mitral regurgitation). The device is inserted through a vein in the leg and clips the valve to reduce leakage. The goal was to see if the procedure is safe and effective, with recovery typically taking two to three days.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
MitraClip device (a catheter-based clip to repair the mitral valve)
What this could lead to
If successful, this could offer a less invasive treatment option for people with mitral regurgitation, reducing symptoms and improving daily life without open-heart surgery.
What could go wrong
This was a small, single-arm study with no comparison group, so results may not apply broadly. Risks include procedural complications like stroke or heart attack.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MITRAL REGURGITATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Fuwai Hospital Chinese Academy of Medical Sciences

    Beijing, Beijing Municipality, China

  • Fuwai Hospital Chinese Academy of Medical Sciences, Shenzhen

    Shenzhen, Guangdong, China

  • The 2nd Affiliated Hospital of Zhejiang University

    Hangzhou, Zhejiang, 310009, China

  • The First Affiliated Hospital of Xi'an Jiaotong University

    Xi'an, Shaanxi, China

  • Xiamen Cardiovascular Hospital Xiamen University

    Xiamen, Fujian, 361008, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.